mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis

Kidney transplant recipients are at high risk of developing severe COVID-19 due to the coexistence of several transplant-related comorbidities (e.g., cardiovascular disease, diabetes) and chronic immunosuppression. As a consequence, a large part of SARS-CoV-2 infected patients have been managed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Simona, Carratù, Pierluigi, Stallone, Giovanni, Zaza, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419255/
https://www.ncbi.nlm.nih.gov/pubmed/34497515
http://dx.doi.org/10.3389/fphar.2021.710543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419255/
https://www.ncbi.nlm.nih.gov/pubmed/34497515
http://dx.doi.org/10.3389/fphar.2021.710543

Ejemplares similares